Compare Dyne Therapeutics Inc. Common Stock (DYN) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dyne Therapeutics Inc. Common Stock vs Stitch Fix Inc — how do they compare? Dyne Therapeutics Inc. Common Stock trades at $15.15 (market cap $2.81B), while Stitch Fix Inc trades at $2.59 (market cap $319.31M). The key difference: Dyne Therapeutics Inc. Common Stock is far larger — about 8.8× Stitch Fix Inc's market cap, and Dyne Therapeutics Inc. Common Stock is more actively traded (2,195,902 versus 2,118,827). Which is the better fit depends on your goals — on Pluang, investors hold Dyne Therapeutics Inc. Common Stock for 0 Days and Stitch Fix Inc for 31 Days on average.
| DYN | SFIX | |
|---|---|---|
Market Cap | $2.81B | $319.31M |
Volume | 2,195,902 | 2,118,827 |
Sector | Health | Consumer Cyclical |
52-Week High | $26.78 | $5.64 |
52-Week Low | $14.60 | $2.16 |
Typical Hold Time | 0 Days | 31 Days |
Enterprise Value | $2.13B | $215.11M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dyne Therapeutics (DYN) trades at $15.30, down 4.14% on the day, reflecting recent volatility amid mixed clinical trial news. The stock is in a neutral technical position with immediate support at $15 and resistance at $16. Fundamentally, the company is a clinical-stage biotech with no revenue, reporting a net loss of $446.21M in 2025, but maintains strong analyst support with an 85.7% buy rating and a $35.20 consensus price target. Recent news highlights progress in Phase 1/2 trials for neuromuscular diseases and a $375M public offering in July 2026 to fund development.
The investment case hinges on clinical success, offering significant upside to the price target, but carries high risk due to pre-revenue status, dependence on trial outcomes, and negative cash flow from operations. Investor sentiment is cautiously optimistic, buoyed by analyst confidence, though volatility from sector-specific news remains a near-term challenge.
Stitch Fix (SFIX) trades at $2.45, down 9.26% in the last session amid bearish technical signals and negative net cash flow. The company shows improving fundamentals with three consecutive quarterly EPS beats and narrowing losses, though revenue remains stagnant at $1.27B. Recent news highlights investor lawsuits and a challenging FY2027 outlook that overshadowed Q4 results.
The stock faces headwinds from weak guidance and negative investor sentiment, but current valuation at 0.24 P/S offers potential for recovery if the company can stabilize client growth and achieve profitability. Key risks include ongoing legal investigations and competitive pressures in the online retail space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dyne Therapeutics Inc. Common Stock
Dyne Therapeutics, Inc. is a clinical-stage biotechnology company developing therapeutics for genetically driven neuromuscular diseases, including Duchenne muscular dystrophy and myotonic dystrophy type 1, with additional preclinical programs for facioscapulohumeral muscular dystrophy and Pompe disease.
Read more on DYN →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
